Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001209191-14-034320
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-15 17:43:10
Reporting Period:
2014-05-13
Filing Date:
2014-05-15
Accepted Time:
2014-05-15 17:43:10
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1423824 Alder Biopharmaceuticals Inc ALDR Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1270734 Deepika Pakianathan C/o Delphi Ventures
3000 Sand Hill Rd., Bldg 1, Suite 135
Menlo Park CA 94025
Yes No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-05-13 2,463,894 $0.00 2,463,894 No 4 C Indirect By Delphi Ventures VII, L.P.
Common Stock Acquisiton 2014-05-13 24,638 $0.00 2,488,532 No 4 C Indirect By Delphi BioInvestments VII, L.P.
Common Stock Acquisiton 2014-05-13 346,535 $10.00 2,835,067 No 4 P Indirect By Delphi Ventures VII, L.P.
Common Stock Acquisiton 2014-05-13 3,465 $10.00 2,838,532 No 4 P Indirect By Delphi BioInvestments VII, L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 C Indirect By Delphi Ventures VII, L.P.
No 4 C Indirect By Delphi BioInvestments VII, L.P.
No 4 P Indirect By Delphi Ventures VII, L.P.
No 4 P Indirect By Delphi BioInvestments VII, L.P.
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Series C Preferred Stock Disposition 2014-05-13 2,083,541 $0.00 2,083,541 $0.00
Common Stock Series D Preferred Stock Disposition 2014-05-13 380,353 $0.00 380,353 $0.00
Common Stock Series C Preferred Stock Disposition 2014-05-13 20,835 $0.00 20,835 $0.00
Common Stock Series D Preferred Stock Disposition 2014-05-13 3,803 $0.00 3,803 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
0 No 4 C Indirect
Footnotes
  1. The preferred stock converted into common stock on a 1-for-1 basis upon the closing of the issuer's initial public offering and had no expiration date.
  2. These securities are directly held by Delphi Ventures VII, L.P. ("DV VII"). Delphi Management Partners VII, L.L.C. ("DMP VII") is the general partner of DV VII and may be deemed to have sole voting and dispositive power over the securities held by DV VII. The Reporting Person is a managing member of DMP VII and may be deemed to share voting and dispositive power over the securities held by DV VII. The Reporting Person disclaims beneficial ownership of the securities held by DV VII, except to the extent of any pecuniary interest therein.
  3. These securities are directly held by Delphi BioInvestments VII, L.P. ("DBI VII"). Delphi Management Partners VII, L.L.C. ("DMP VII") is the general partner of DBI VII and may be deemed to have sole voting and dispositive power over the securities held by DBI VII. The Reporting Person is a managing member of DMP VII and may be deemed to share voting and dispositive power over the securities held by DBI VII. The Reporting Person disclaims beneficial ownership of the securities held by DBI VII, except to the extent of any pecuniary interest therein.